Investor Relations Home

Webcast ImageWebcast
Q4 2016 IRIDEX Earnings Conference Call (Live)
03/08/17 at 2:00 p.m. PT
Q4 2016 IRIDEX Earnings Conference Call
Wednesday, March 8, 2017 2:00 p.m. PT  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
IRIDEX Corporation was founded in 1989 and is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology market. We maintain a deep commitment to the success of our customers, with comprehensive technical, clinical, and service support programs. IRIDEX is dedicated to a standard of excellence, offering superior technology for superior results. IRIDEX products are sold in the United States through a direct sales force and internationally through a combination of a direct sales force and a network of approximately 70 independent distributors into over 100 countries.
Stock Quote
IRIX (Common Stock)
ExchangeNASDAQ (US Dollar)
Change (%) Stock is Down 0.06 (0.39%)
Data as of 02/24/17 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Recent NewsMore >>
02/22/17IRIDEX to Report Fourth Quarter and 2016 Financial Results on March 8, 2017
MOUNTAIN VIEW, Calif., Feb. 22, 2017 /PRNewswire/ -- IRIDEX Corporation (Nasdaq: IRIX) today announced that it will release financial results for the fourth quarter and 2016 after the close of trading on Wednesday, March 8, 2017.  The Company's management team will host a corresponding conference call beginning at 2:00 p.m. PT / 5:00 p.m. ET. Investors interested in listening to the conference call may do so by dialing (844) 707-0665 for domestic callers or (703) 326-3030 for inter... 
Printer Friendly Version
01/31/17BioTuesdays: Iridex MicroPulse Probes Glaucoma Continuum of Care
Printer Friendly Version
01/09/17IRIDEX Announces Preliminary Unaudited Revenues for 2016 Fourth Quarter and Full Year
MOUNTAIN VIEW, Calif., Jan. 9, 2017 /PRNewswire/ -- IRIDEX Corporation (Nasdaq: IRIX) today reported preliminary revenues of approximately $12.4 to $12.5 million and $46.0 to $46.1 million for the fourth quarter and full year 2016, respectively, meeting the previously provided quarterly and full year guidance provided by the Company.  Revenue growth compared to fourth quarter and full year 2015 was driven by the Company's new flagship Cyclo G6™ glaucoma laser platform that is powered b... 
Printer Friendly Version
12/09/16IRIDEX Corporation Prices Public Offering of Common Stock
MOUNTAIN VIEW, Calif., Dec. 9, 2016 /PRNewswire/ -- IRIDEX Corporation (NASDAQ: IRIX) today announced the pricing of its underwritten public offering of an aggregate of 1.15 million shares of common stock at a price of $14.00 per share, $0.01 par value (the "Offering" with such shares being the "Shares").  IRIDEX expects to receive gross proceeds of $16.1 million, before deducting underwriting discounts and other estimated offering expenses. IRIDEX has also granted the underwriters a 3... 
Printer Friendly Version
Primary IR Contact
Lynn Lewis or Leigh Salvo
Phone: (415) 937-5404

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

logo aa0logo agslogo ascrslogo asrslogo esrs0logo euretina